Accolade Sale Purchase Of Stock from 2010 to 2024

ACCD Stock  USD 3.57  0.22  5.80%   
Accolade's Sale Purchase Of Stock is increasing over the years with stable fluctuation. Sale Purchase Of Stock is expected to dwindle to about 4.3 M. During the period from 2010 to 2024 Accolade Sale Purchase Of Stock annual values regression line had geometric mean of  4,120,233 and mean square error of 24931.7 T. View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
2010-12-31
Previous Quarter
4.5 M
Current Value
4.3 M
Quarterly Volatility
157 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Accolade financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accolade's main balance sheet or income statement drivers, such as Tax Provision of 1.3 M, Net Interest Income of 6.2 M or Interest Income of 218 K, as well as many indicators such as Price To Sales Ratio of 1.89, Dividend Yield of 0.0 or PTB Ratio of 1.81. Accolade financial statements analysis is a perfect complement when working with Accolade Valuation or Volatility modules.
  
Check out the analysis of Accolade Correlation against competitors.
For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.

Latest Accolade's Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of Accolade over the last few years. It is Accolade's Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Accolade's overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Pretty Stable
   Sale Purchase Of Stock   
       Timeline  

Accolade Sale Purchase Of Stock Regression Statistics

Arithmetic Mean65,759,080
Geometric Mean4,120,233
Coefficient Of Variation238.73
Mean Deviation102,767,445
Median773,000
Standard Deviation156,985,706
Sample Variance24644.5T
Range450.4M
R-Value0.25
Mean Square Error24931.7T
R-Squared0.06
Significance0.38
Slope8,641,877
Total Sum of Squares345023.2T

Accolade Sale Purchase Of Stock History

20244.3 M
20234.5 M
2022M
202113.2 M
2019451.1 M
201850.9 M

About Accolade Financial Statements

Accolade stakeholders use historical fundamental indicators, such as Accolade's Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Although Accolade investors may analyze each financial statement separately, they are all interrelated. For example, changes in Accolade's assets and liabilities are reflected in the revenues and expenses on Accolade's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Accolade. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sale Purchase Of Stock4.5 M4.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Accolade is a strong investment it is important to analyze Accolade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Accolade's future performance. For an informed investment choice regarding Accolade Stock, refer to the following important reports:
Check out the analysis of Accolade Correlation against competitors.
For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.02)
Revenue Per Share
5.706
Quarterly Revenue Growth
0.098
Return On Assets
(0.07)
Return On Equity
(0.19)
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.